Cargando…

Variant fatty acid-like molecules Conjugation, novel approaches for extending the stability of therapeutic peptides

The multiple physiological properties of glucagon-like peptide-1 (GLP-1) make it a promising drug candidate for the treatment of type 2 diabetes. However, the in vivo half-life of GLP-1 is short due to rapid degradation by dipeptidyl peptidase-IV (DPP-IV) and renal clearance. The poor stability of G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ying, Wang, Yuli, Wei, Qunchao, Zheng, Xuemin, Tang, Lida, Kong, Dexin, Gong, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676015/ https://www.ncbi.nlm.nih.gov/pubmed/26658631 http://dx.doi.org/10.1038/srep18039

Ejemplares similares

Controlled release strategy of paclitaxel by conjugating to matrix metalloproteinases-2 sensitive peptide
por: Huang, Changjiang, et al.
Publicado: (2016)

Effect of Extending the Conjugation of Dye Molecules on the Efficiency and Stability of Dye-Sensitized Solar Cells
por: Zhou, Pengjuan, et al.
Publicado: (2021)

Potent tumor targeting drug release system comprising MMP-2 specific peptide fragment with self-assembling characteristics
por: Hua, Dan, et al.
Publicado: (2014)

Glycosaminoglycan Conjugation for Improving the Duration of Therapeutic Action of Glucagon-Like Peptide-1
por: Ichikawa, Megumi, et al.
Publicado: (2018)

Evidence of Extended Thermo-Stability of Typhoid Polysaccharide Conjugate Vaccines
por: Gao, Fang, et al.
Publicado: (2021)

Delivery of a peptide-drug conjugate targeting the blood brain barrier improved the efficacy of paclitaxel against glioma
por: Li, Ying, et al.
Publicado: (2016)

Specific peptide conjugation to a therapeutic antibody leads to enhanced therapeutic potency and thermal stability by reduced Fc dynamics
por: Kiyoshi, Masato, et al.
Publicado: (2023)

Peptide Conjugates with Small Molecules Designed to Enhance Efficacy and Safety
por: He, Rongjun, et al.
Publicado: (2019)

Molecular Engineering of Peptide–Drug Conjugates for Therapeutics
por: Fang, Yu, et al.
Publicado: (2022)

Light-up properties of complexes between thiazole orange-small molecule conjugates and aptamers
por: Pei, Renjun, et al.
Publicado: (2009)

Decoupling stability and release in disulfide bonds with antibody-small molecule conjugates
por: Pillow, Thomas H., et al.
Publicado: (2017)

Myelin Peptide–Mannan Conjugate Multiple Sclerosis Vaccines: Conjugation Efficacy and Stability of Vaccine Ingredient
por: Matsoukas, John, et al.
Publicado: (2021)

Synthesis, Characterization, and Retinol Stabilization of Fatty Amide-β-cyclodextrin Conjugates
por: Kim, Hwanhee, et al.
Publicado: (2016)

Covalent conjugation of extracellular vesicles with peptides and nanobodies for targeted therapeutic delivery
por: Pham, Tin Chanh, et al.
Publicado: (2021)

Generation of therapeutic protein variants with the human serum albumin binding capacity via site-specific fatty acid conjugation
por: Cho, Jinhwan, et al.
Publicado: (2017)

Conjugation as a Tool in Therapeutics: Role of Amino Acids/Peptides-Bioactive (Including Heterocycles) Hybrid Molecules in Treating Infectious Diseases
por: Gattu, Rohith, et al.
Publicado: (2023)

Comparing Variants of the Cell-Penetrating Peptide sC18 to Design Peptide-Drug Conjugates
por: Grabeck, Joshua, et al.
Publicado: (2022)

Small Molecule–Peptide Conjugates as Dimerization Inhibitors of Leishmania infantum Trypanothione Disulfide Reductase
por: Revuelto, Alejandro, et al.
Publicado: (2021)

Tumor-targeted delivery of siRNA using fatty acyl-CGKRK peptide conjugates
por: Sharma, Meenakshi, et al.
Publicado: (2017)

Fatty Acids/Tetraphenylethylene Conjugates: Hybrid AIEgens for the Preparation of Peptide-Based Supramolecular Gels
por: Impresari, Elisa, et al.
Publicado: (2022)

Boron-mediated sequential alkyne insertion and C–C coupling reactions affording extended π-conjugated molecules
por: Shoji, Yoshiaki, et al.
Publicado: (2016)

Peptide–nanoparticle conjugates: a next generation of diagnostic and therapeutic platforms?
por: Jeong, Woo-jin, et al.
Publicado: (2018)

Conjugates for use in peptide therapeutics: A systematic review and meta-analysis
por: Wijesinghe, Ashan, et al.
Publicado: (2022)

Electronic Conductance and Thermopower of Cross-Conjugated and Skipped-Conjugated Molecules in Single-Molecule Junctions
por: Salthouse, Rebecca J., et al.
Publicado: (2023)

Research advances in peptide‒drug conjugates
por: Gong, Liming, et al.
Publicado: (2023)

Self‐Stabilized Supramolecular Assemblies Constructed from PEGylated Dendritic Peptide Conjugate for Augmenting Tumor Retention and Therapy
por: Zheng, Xiuli, et al.
Publicado: (2021)

Nanoparticles as Carriers of Proteins, Peptides and Other Therapeutic Molecules
por: Pudlarz, Agnieszka, et al.
Publicado: (2018)

Solution behavior and encapsulation properties of fatty acid–elastin-like polypeptide conjugates
por: Zhang, Tingting, et al.
Publicado: (2023)

Solvent-Induced Supramolecular Assembly of a Peptide-Tetrathiophene-Peptide Conjugate
por: Guo, Zongxia, et al.
Publicado: (2019)

N-terminal selective conjugation method widens the therapeutic window of antibody–drug conjugates by improving tolerability and stability
por: Ko, Min Ji, et al.
Publicado: (2021)

Extended Applications of Small-Molecule Covalent Inhibitors toward Novel Therapeutic Targets
por: Lee, Jesang, et al.
Publicado: (2022)

Therapeutic Mechanisms and Clinical Effects of Glucagon-like Peptide 1 Receptor Agonists in Nonalcoholic Fatty Liver Disease
por: Lee, Han Ah, et al.
Publicado: (2023)

Immunomodulatory Response of Toll-like Receptor Ligand–Peptide Conjugates in Food Allergy
por: Losada Méndez, Jorge, et al.
Publicado: (2021)

Myricetin: a potent approach for the treatment of type 2 diabetes as a natural class B GPCR agonist
por: Li, Ying, et al.
Publicado: (2017)

TEPITOPEpan: Extending TEPITOPE for Peptide Binding Prediction Covering over 700 HLA-DR Molecules
por: Zhang, Lianming, et al.
Publicado: (2012)

Biocatalysts Based on Peptide and Peptide Conjugate Nanostructures
por: Hamley, Ian W.
Publicado: (2021)

Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells
por: Kalimuthu, Kalishwaralal, et al.
Publicado: (2018)

Conjugation with gold nanoparticles improves the stability of the KT2 peptide and maintains its anticancer properties
por: Maraming, Pornsuda, et al.
Publicado: (2021)

Rapid optimization and prototyping for therapeutic antibody-like molecules
por: Xu, Lihui, et al.
Publicado: (2013)

Extended Intravitreal Rabbit Eye Residence of Nanoparticles Conjugated With Cationic Arginine Peptides for Intraocular Drug Delivery: In Vivo Imaging
por: Melgar-Asensio, Ignacio, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_237mkcjh3q3tj129nhh1chc693